PTC Therapeutics (PTCT) Tops Q4 EPS by 17c, Beats on Revenues; Offers FY18 Revenue Outlook Above Consensus
Go back to PTC Therapeutics (PTCT) Tops Q4 EPS by 17c, Beats on Revenues; Offers FY18 Revenue Outlook Above Consensus| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 65.96 +0.70 (1.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.26 | 52 Week High | $35.40 | |||
| Open | $66.24 | 52 Week Low | $4.03 | |||
| Day High | $66.58 | P/E | 7.02 | |||
| Day Low | $65.36 | EPS | $9.40 | |||
| Volume | 1,307,236 | |||||
